25 – 29 September 2015 / Austria, Vienna

25 - 29 September 2015 / Austria, Vienna

Use of Early tumor shrinkage to as a predictor forpredict long-term outcome in patients with unresectable liver metastases from wt-KRAS colorectal cancer treated with hepatic artery infusion of Irinotecan, 5-Fluorouracil and Oxaliplatine plus intravenous Cetuximab after failure of one to three systemic protocols (European phase II clinical trial NCT00852228). Bouchahda M, Boige V, Smith D, Karaboué A, Hebbar M, Lepère C, Focan C, Guimbaud R, Innominato P, Awad S, Carvalho C, Tumolo S, Truant S, De Baere T, Castaing D, Rougier P, Morère JF, Ducreux M, Adam R and Lévi F, on behalf of ARTBC International.

Pas de commentaire.

Ajouter un commentaire